Thrivent Financial for Lutherans’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Sell
29,013
-10,087
-26% -$525K ﹤0.01% 1539
2025
Q1
$2.5M Sell
39,100
-106
-0.3% -$6.76K 0.01% 1139
2024
Q4
$1.87M Sell
39,206
-193,810
-83% -$9.26M ﹤0.01% 1480
2024
Q3
$13.3M Sell
233,016
-709,813
-75% -$40.6M 0.03% 592
2024
Q2
$49.4M Sell
942,829
-772,015
-45% -$40.4M 0.1% 261
2024
Q1
$69.8M Sell
1,714,844
-206,815
-11% -$8.41M 0.14% 198
2023
Q4
$71M Sell
1,921,659
-92,574
-5% -$3.42M 0.15% 188
2023
Q3
$76.9M Sell
2,014,233
-64,605
-3% -$2.47M 0.18% 149
2023
Q2
$75M Buy
2,078,838
+1,002,122
+93% +$36.1M 0.17% 173
2023
Q1
$41.1M Buy
1,076,716
+157,080
+17% +$6M 0.1% 262
2022
Q4
$52.3M Sell
919,636
-398,096
-30% -$22.7M 0.14% 208
2022
Q3
$52.1M Sell
1,317,732
-8,326
-0.6% -$329K 0.14% 197
2022
Q2
$58.3M Sell
1,326,058
-140,910
-10% -$6.2M 0.16% 180
2022
Q1
$58.5M Buy
1,466,968
+390,135
+36% +$15.6M 0.11% 217
2021
Q4
$43.3M Buy
1,076,833
+323,585
+43% +$13M 0.08% 277
2021
Q3
$30.6M Sell
753,248
-14,460
-2% -$588K 0.06% 346
2021
Q2
$34.9M Buy
767,708
+33,732
+5% +$1.53M 0.07% 313
2021
Q1
$30.6M Sell
733,976
-512,639
-41% -$21.4M 0.07% 334
2020
Q4
$53.2M Buy
1,246,615
+56,814
+5% +$2.43M 0.12% 214
2020
Q3
$31.3M Buy
1,189,801
+10,423
+0.9% +$274K 0.08% 288
2020
Q2
$31.6M Buy
1,179,378
+5,170
+0.4% +$139K 0.09% 262
2020
Q1
$21.1M Sell
1,174,208
-3,232
-0.3% -$58.1K 0.08% 307
2019
Q4
$20.9M Sell
1,177,440
-2,688,279
-70% -$47.7M 0.06% 368
2019
Q3
$60M Buy
3,865,719
+80,054
+2% +$1.24M 0.19% 141
2019
Q2
$65M Buy
3,785,665
+115,835
+3% +$1.99M 0.2% 133
2019
Q1
$59.1M Buy
3,669,830
+107,325
+3% +$1.73M 0.19% 152
2018
Q4
$52.1M Buy
3,562,505
+426,775
+14% +$6.24M 0.19% 135
2018
Q3
$57M Buy
3,135,730
+819,593
+35% +$14.9M 0.18% 145
2018
Q2
$39.1M Buy
+2,316,137
New +$39.1M 0.13% 166